A detailed history of Davidson Capital Management Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Davidson Capital Management Inc. holds 190 shares of NVO stock, worth $9,207. This represents 0.0% of its overall portfolio holdings.

Number of Shares
190
Holding current value
$9,207
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$45.38 - $71.7 $8,622 - $13,623
190 New
190 $10,000
Q4 2023

Feb 08, 2024

BUY
$87.78 - $105.45 $6,320 - $7,592
72 New
72 $7,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $109B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Davidson Capital Management Inc. Portfolio

Follow Davidson Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davidson Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Davidson Capital Management Inc. with notifications on news.